Multi-country monkeypox outbreak in non-endemic countries

24 May 2022
News release
Since 13 May 2022, cases of monkeypox have been reported to WHO from 19 Member States that are not endemic for monkeypox virus, across four WHO regions. There are 157 confirmed cases so far, and 117 pending investigations. More cases are likely to be reported as surveillance expands.

As of now no cases have been reported from the South-East Asia Region. Epidemiological investigations are ongoing, however, reported cases thus far have no established travel links to endemic areas.

Monkeypox is usually a self-limited disease with the symptoms lasting from 2 to 4 weeks. Severe cases can occur. In recent times, the case fatality ratio has been around 3-6%. Monkeypox is transmitted to humans through close contact with an infected person or animal, or with material contaminated with the virus. Monkeypox virus is transmitted from one person to another by close contact with lesions, body fluids, respiratory droplets and contaminated materials such as bedding.

Symptoms include:

  • Rash with blisters on face, hands, feet, eyes, mouth and/or genitals
  • Fever
  • Swollen lymph nodes
  • Headaches
  • Muscle aches
  • Low energy

 
The clinical presentation of monkeypox resembles that of smallpox, a related orthopoxvirus infection which was declared eradicated worldwide in 1980. Monkeypox is less contagious than smallpox and causes less severe illness.

Vaccines used during the smallpox eradication programme also provided protection against monkeypox. Newer vaccines have been developed of which one has been approved for prevention of monkeypox. An antiviral agent developed for the treatment of smallpox has also been licensed for the treatment of monkeypox.

Some cases have been identified through sexual health clinics in communities of gay, bisexual and other men who have sex with men. It is important to note that the risk of monkeypox is not limited to men who have sex with men. Anyone who has close contact with someone who is infectious is at risk.

However, given that the virus is being identified in these communities, learning about monkeypox will help ensure that as few people as possible are affected and that the outbreak can be stopped.

Monkeypox spreads differently from COVID-19. WHO encourages people to stay informed from reliable sources, such as national health authorities, on the extent of the outbreak in their community (if any), symptoms and prevention.

As monkeypox spreads through close contact, the response should focus on the people affected and their close contacts. People who closely interact with someone who is infectious are at greater risk for infection: this includes health workers, household members and sexual partners.

Stigmatizing groups of people because of a disease is never acceptable. It can be a barrier to ending an outbreak as it may prevent people from seeking care, and lead to undetected spread.

WHO is working with the affected countries and others to expand disease surveillance to find and support people who may be affected, and to provide guidance on how to manage the disease. As the situation is evolving, WHO will continue to provide updates as we learn more.

 

WHO fact sheet on Monkeypox available here

https://www.who.int/news-room/fact-sheets/detail/monkeypox

Monkeypox Q&A available here

https://www.who.int/news-room/questions-and-answers/item/monkeypox/